AMGEN Kyprolis (carfilzomib) for injection, 30 mg per vial, Discard unused portion, For Intravenous Administration Only, Rx Only, Manufactured for: Onyx Pharmaceuticals, Inc., Thousand Oaks, CA 91320-1799, U.S.A., NDC 76075-102-01
Published December 28, 2016 · Recall initiated: December 15, 2016
Summary
FDA records drug Class II recall D-0226-2017, published December 28, 2016 and initiated December 15, 2016. Recalling firm: Amgen, Inc.; Status: Terminated; Reported quantity: 11,434 vials; Lot: Lot #1071559, 1071629; Exp. 05/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: Potential cracks in glass vials
What to do
Voluntary: Firm initiated · Letter
Get an email if KYPROLIS has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- KYPROLIS
- Manufacturer
- Amgen, Inc.
- Distributor
- United States and Puerto Rico No foreign distribution.
- Lot
- Lot #1071559, 1071629; Exp. 05/18
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAToms of Maine Naturally Dry Natural Powder Antiperspirant Stick, Distributed by: Tom's of Maine, Kennebunk,December 28, 2016
- FDAPhenylephrine 2.5% + Tropicamide 1% Compounded Eye Drops Solution, 5 mL bottles, Meta Pharmacy Services. NDCDecember 28, 2016
- FDADuloxetine Delayed-release Capsules USP 30 mg 30-count bottles, Rx Only, Manufactured by: Inventia HealthcareDecember 28, 2016
- FDACOMFORT SHIELD (dimethicone) Barrier Cream Cloths, 3%, packaged as impregnated cloths wrapped in flexibleDecember 28, 2016
- FDASkinny Bee Diet capsules, 500 mg, packaged in a 60-count bottleDecember 28, 2016
- FDA2% Chlorhexidine Gluconate* Cloth, 2 disposable cloths per package, further packaged into 96 packages perDecember 28, 2016
Questions about this recall
Was AMGEN Kyprolis (carfilzomib) for injection, 30 mg per vial, Discard unused portion, For Intravenous Administration Only, Rx Only, Manufactured for: Onyx Pharmaceuticals, Inc., Thousand Oaks, CA 91320-1799, U.S.A., NDC 76075-102-01 recalled?
Yes. FDA published recall D-0226-2017 on December 28, 2016. Reported hazard: Lack of Assurance of Sterility: Potential cracks in glass vials
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: KYPROLIS.